(Q44459245)

English

Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group

scientific article published in June 2003

Statements

Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group (English)
Henning Mouridsen
Mikhail Gershanovich
Ramon Perez-Carrion
Justus Apffelstaedt
Dominique Becquart
Poonamalle P Bapsy
Hilary Chaudri-Ross

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit